Global Journal of Medical Research, K: Interdisciplinary, Volume 22 Issue 3

Investig Vinculación, Docencia y Gestión [Internet]. 2017 Dec 28; 2(4, Dic): 156–60. Available 7. Chen P, Xu H, Tang H, Zhao F, Yang C, Kwok LY, et al. Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis. MicrobBiotechnol [Internet]. 2020 Nov 1 [cited 2021 Dec 22]; 13(6): 2032–43. Available from: https://onlinelibrary.wiley.com/doi/ full/10.1111/1751-7915.13661 8. Coppola M de M, Gil-Turnes C. Probióticos e resposta imune. Ciência Rural. 2004 Aug [cited 2021 Apr 21]; 34(4): 1297–303. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&a mp;pid=S010384782004000400056&lng=pt& amp;tlng=pt 9. Currò D, Ianiro G, Pecere S, Bibbò S, Cammarota G. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Vol. 174, BritishJournal of Pharmacology. John Wiley and Sons Inc.; 2017. p. 1426–49. https:// onlinelibrary.wiley.com/doi/10.1111/j.1365-2036. 2011.04939.x 10. Friedrich JACV, Fariña LO de. Uso de probióticos em doenças autoimunes gastrointestinais: Uma revisão sistemática / The use ofprobiotics in gastrointestinal autoimmunediseases: A systematic review. Brazilian J Heal Rev. 2020; 3(6). 11. Gentschew L, Ferguson LR. Role of nutrition and microbiota Gentschew, L., & Ferguson, L. R. (2012). Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Molecular Nutrition & Food Research, 56(4), 524–535 .https://doi.org/10.1002/mnfr.201100630in susc. Mol Nutr Food Res [Internet]. 2012 Apr 1 [cited 2021 Apr 27]; 56(4):524–35. Available from: http://doi.wiley.com/10.1002/mnfr.201100630 12. Hedin CRH, Mullard M, Sharratt E, Jansen C, Sanderson JD, Shirlaw P, et al. Probiotic and prebiotic use in patients with inflammatory bowel disease: A case-control study. Inflamm Bowel Dis [Internet]. 2010 Dec 1 [cited 2021 May 10]; 16(12): 2099–108. Available from: https://academic.oup . com/ibdjournal/article/16/12/2099/4628298 13. Hirano A, Umeno J, Okamoto Y, Shibata H, Ogura Y, Moriyama T, et al. Comparison of the microbial community structure between inflamed and non- inflamed sites in patients with ulcerative colitis. J Gastroenterol Hepatol [Internet]. 2018 Sep 1 [cited 2021 Dec 22]; 33(9): 1590–7. Available from: https:// pubmed.ncbi.nlm.nih.gov/29462845/ 14. Huynh HQ, deBruyn J, Guari L, Diaz H, Li M, Girgis S, et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: A pilot study. Inflamm Bowel Dis. 2009; 15(5): 760–8. 15. Libânio J, Frazão K, Cunha M, Maria Simplicio Revoredo C, Maria Simplicio Revoredo - C. Doença de Crohn e Probióticos: uma revisão Crohn’s Disease and Probiotics: a review Endereço para correspondência: Palavras-chave. 2017; 7894(2): 67–73. 16. Limketkai BN, Akobeng AK, Gordon M, Adepoju AA. Probiotics for induction of remission in Crohn’s disease. John Wiley and Sons Ltd; 2020 Jul 17. 17. Matthes H, Krummenerl T, Giensch M, Wolff C, Schulze J. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern Med [Internet]. 2010 Apr 15 [cited 2021 Jul 17]; 10(13): 13. Available from: https://pubmed.ncbi.nlm.nih.gov/20398311/ 18. Meligrana NE, Quera R, Figueroa C, Ibáñez P, Lubascher J, Kronberg U, et al. Factores ambientales en el desarrollo y evolución de la enfermedad inflamatória intestinal [Internet]. Vol. 147, Revista medica de Chile. NLM (Medline); 2019 [cited2021 Apr 26]. p. 212–20. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext&a mp;pid=S003498872019000200212&lng=es& amp;nrm=iso&tlng=es 19. Mohajeri MH, Brummer RJM, Rastall RA, Weersma RK, Harmsen HJM, Faas M, et al. The role of the microbiome for human health: from basic science to clinical applications. Eur J Nutr [Internet]. 2018 May 1 [cited 2021 Apr 26]; 57(3): 1–14. Available from: https://doi.org/10.1007/s00394-018-1703-4 20. Nishino K, Nishida • Atsushi, Inoue R, Kawada Y, Ohno • Masashi, Sakai S, et al. Analysis of endoscopic brush samples identified mucosa- associated dysbiosis in inflammatory bowel disease. 21. Naidoo K, Gordon M, Fagbemi AO, Thomas AG, Akobeng AK. Probiotics for maintenance of remission in ulcerative colitis. Cochrane database Syst Rev [Internet]. 2011 Dec 7 [cited 2021 Dec 22]; (12). Available from: https://pubmed.ncbi.nlm.nih. gov/22161412/ 22. Sánchez-Morales. Efectividad de probióticos encolitis ulcerativa. Rev Med Inst Mex Seguro Soc. 2017 Aug; 9–14. Sung MK, Park MY. Nutritional modulators of ulcerative colitis: Clinical efficacies and mechanistic view. World J Gastroenterol [Internet]. 2013 [cited 2021 May 10]; 19(7): 994– 1004. Available from: https://www.wjgnet.com/1007- 9327/full/v19/i7/994.htm 23. Sci-Hub | Gut mucosal virome alterations in ulcerative colitis. Gut, 68(7), 1169–1179 | 10.1136/gutjnl-2018-318131. [cited 2021 Dec 22]. Available from: https://sci-hub.ru/10.1136/gutjnl- 2018-318131 24. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011; 140(6): 1756-1767.e1. 52 Year 2022 Global Journal of Medical Research Volume XXII Issue III Version I ( D ) K © 2022 Global Journals The Therapeutic use of Probiotics in Patients with Ulceractive Retocolitis: A Systematic Review